HEAD AND NECK CANCERS

Clinical trials for HEAD AND NECK CANCERS explained in plain language.

Never miss a new study

Get alerted when new HEAD AND NECK CANCERS trials appear

Sign up with your email to follow new studies for HEAD AND NECK CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 2 Not yet finished but already full! 1 Completed 5 Terminated 2

New cancer drug IDE161 enters human testing

Disease control Ongoing

This early-stage trial is testing a new drug called IDE161, alone or with the immunotherapy pembrolizumab, in adults with advanced solid tumors (like breast, ovarian, prostate, or lung cancer). The main goals are to check safety, find the right dose, and get a first look at wheth…

Matched conditions: HEAD AND NECK CANCERS

Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC

HEAD AND NECK CANCERS

Get alerted when new HEAD AND NECK CANCERS trials appear

New cancer drug IDE161 enters human testing